152 related articles for article (PubMed ID: 32416199)
1. Protein promiscuity in drug discovery, drug-repurposing and antibiotic resistance.
Gupta MN; Alam A; Hasnain SE
Biochimie; 2020 Aug; 175():50-57. PubMed ID: 32416199
[TBL] [Abstract][Full Text] [Related]
2. Drugs, host proteins and viral proteins: how their promiscuities shape antiviral design.
Gupta MN; Roy I
Biol Rev Camb Philos Soc; 2021 Feb; 96(1):205-222. PubMed ID: 32918378
[TBL] [Abstract][Full Text] [Related]
3. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
4. [Drug promiscuity].
Guo ZR
Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
[TBL] [Abstract][Full Text] [Related]
5. Rational application of drug promiscuity in medicinal chemistry.
Mei Y; Yang B
Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
[TBL] [Abstract][Full Text] [Related]
6. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
Chartier M; Morency LP; Zylber MI; Najmanovich RJ
BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
[TBL] [Abstract][Full Text] [Related]
7. Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?
Morales JF; Alberca LN; Chuguransky S; Di Ianni ME; Talevi A; Ruiz ME
Curr Top Med Chem; 2018; 18(13):1110-1122. PubMed ID: 30068278
[TBL] [Abstract][Full Text] [Related]
8. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
Bolz SN; Schroeder M
Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
[TBL] [Abstract][Full Text] [Related]
9. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
[TBL] [Abstract][Full Text] [Related]
10. Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.
Haupt VJ; Daminelli S; Schroeder M
PLoS One; 2013; 8(6):e65894. PubMed ID: 23805191
[TBL] [Abstract][Full Text] [Related]
11. Compound promiscuity: what can we learn from current data?
Hu Y; Bajorath J
Drug Discov Today; 2013 Jul; 18(13-14):644-50. PubMed ID: 23524195
[TBL] [Abstract][Full Text] [Related]
12. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
13. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
Dimova D; Hu Y; Bajorath J
J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
[TBL] [Abstract][Full Text] [Related]
14. Can we discover pharmacological promiscuity early in the drug discovery process?
Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M
Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136
[TBL] [Abstract][Full Text] [Related]
15. Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.
Atkins WM
J Steroid Biochem Mol Biol; 2015 Jul; 151():3-11. PubMed ID: 25218442
[TBL] [Abstract][Full Text] [Related]
16. Determining the Degree of Promiscuity of Extensively Assayed Compounds.
Jasial S; Hu Y; Bajorath J
PLoS One; 2016; 11(4):e0153873. PubMed ID: 27082988
[TBL] [Abstract][Full Text] [Related]
17. Identifying and characterizing promiscuous targets: implications for virtual screening.
Pérez-Nueno VI; Ritchie DW
Expert Opin Drug Discov; 2012 Jan; 7(1):1-17. PubMed ID: 22468890
[TBL] [Abstract][Full Text] [Related]
18. GES polypharmacology fingerprints: a novel approach for drug repositioning.
Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters.
Atkins WM
FEBS J; 2020 Apr; 287(7):1306-1322. PubMed ID: 31663687
[TBL] [Abstract][Full Text] [Related]
20. Applications of promiscuity of FDA-approved kinase inhibitors in drug repositioning and toxicity.
Korikani M; Fathima N; Nadiminti G; Akula S; Kancha RK
Toxicol Appl Pharmacol; 2023 Apr; 465():116469. PubMed ID: 36918129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
